Journals / Turkish Journal of Medical Sciences / 2011 / Cilt: 41 - Sayı: 1

Management of community-acquired acute bacterial cystitis in Turkey

Pages
149–157
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: According to local Turkish data, caution is really indicated in rational antibiotic use in the community since the traditional drugs used in the management of CA-ABC are being lost steadily.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Community acquired acute bacterial cystitis (CA-ABC) is one of the most common infectious presentations in the community.
📊
Key Findings & Data:Moreover, quinolones seem to be at the edge with resistance rates up to 20%.
💡
Conclusion & Impact:Conclusion: According to local Turkish data, caution is really indicated in rational antibiotic use in the community since the traditional drugs used in the management of CA-ABC are being lost steadily.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Community-acquired · urinary · infection

Abstract

Community acquired acute bacterial cystitis (CA-ABC) is one of the most common infectious presentations in the community. This paper aims to provide a rational approach in the management of CA-ABC based on local Turkish data. Materials and methods: The publications evaluating the microbiological data obtained from CA-ABC cases were searched in both Turkish and international databases. Results: Fosfomycin and nitrofurantain appear to be baseline antibiotics while the empirical use of trimethoprim sulfamethoxazole, amoxicillin clavulanate, and first and second generation cephalosporins seems to be unreliable in Turkey. Moreover, quinolones seem to be at the edge with resistance rates up to 20%. On the other hand, aminoglicosides, third and fourth generation cephalosporins, and piperacillin-tazobactam look more trustworthy. Conclusion: According to local Turkish data, caution is really indicated in rational antibiotic use in the community since the traditional drugs used in the management of CA-ABC are being lost steadily.

Özet

Community acquired acute bacterial cystitis (CA-ABC) is one of the most common infectious presentations in the community. This paper aims to provide a rational approach in the management of CA-ABC based on local Turkish data. Materials and methods: The publications evaluating the microbiological data obtained from CA-ABC cases were searched in both Turkish and international databases. Results: Fosfomycin and nitrofurantain appear to be baseline antibiotics while the empirical use of trimethoprim sulfamethoxazole, amoxicillin clavulanate, and first and second generation cephalosporins seems to be unreliable in Turkey. Moreover, quinolones seem to be at the edge with resistance rates up to 20%. On the other hand, aminoglicosides, third and fourth generation cephalosporins, and piperacillin-tazobactam look more trustworthy. Conclusion: According to local Turkish data, caution is really indicated in rational antibiotic use in the community since the traditional drugs used in the management of CA-ABC are being lost steadily.

🔖

Cite This Article

AVCI, A., ERDEM, H., COŞKUN, Ö. (2022). Management of community-acquired acute bacterial cystitis in Turkey. Turkish Journal of Medical Sciences, Cilt: 41 - Sayı: 1, 149–157. https://ajindex.com/articles/611343

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Alam MF, Cohen D, Butler C, Dunstan F, Roberts Z, Hillier S et al. The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice. Int J Antimicrob Agents, 2008; 15:(Epub ahead of print). Sobel JD, Kaye D. Urinary Tract Infections. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 6 ed: Churchill Livingstone 2005: 875-904.
  2. McCarty JM, Richard G, Huck W, Tucker RM, Tosiello RL, Shan M et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. The American Journal of Medicine, 1999; 106: 292-9.
  3. Nicolle L, Anderson PA, Conly J, Mainprize TC, Meuser J, Nickel JC et al. Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physicia,. 2006; 52: 612-8.
  4. McQuilkin M, Lund A, Palmer W. Antimicrobial resistance of uncomplicated urinary tract infections in northern Utah. Clin Lab Sci, 2008; 21: 99-101. Schaeffer AJ. The expanding role of fluoroquinolones. Am J Med, 2002; 113: 45-54.
  5. Biswas D, Gupta P, Prasad R, Singh V, Arya M, Kumar A. Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance. Indian J Med Sci, 2006; 60: 53-8. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis, 2000; 19: 112-7. 18. Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J Med Res, 2004; 120: 553-56. Amsden GW. Tables of antimicroal agent pharmacology. In: Mandel GL BJDR, ed. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone, 2000: 551-603.
  6. Gagliotti C, Buttazzi R, Sforza S, Moro ML. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli, J Infect. 2008; 57: 179-84.
  7. Baykan M, Kaya M, Arslan U, Baysal B. İdrar örneklerinden izole edilen E.coli suşlarının antimikrobiyallere duyarlılıklarının değerlendirilmesi (The evaluation of antibiotic susceptibility patterns of E.coli strains isolat